Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

L.A. McKeown

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

L.A. McKeown

August 11, 2016

News Daily News

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

News Daily News

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

Caitlin E. Cox

May 08, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

L.A. McKeown

September 20, 2013

News Daily News

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

L.A. McKeown

September 20, 2013

Presentation TCT 2013

Importance of Optimal Reperfusion in Diabetic Patients Treated with Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Presenter: M.A. Velders, H. Boden, B.L. van der Hoeven, AACM Heestermans, VAWM Umans, SH Hofma, JW Jukema, M.J. Schalij, A. J. van Boven

January 31, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

Advertisement

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

Importance of Optimal Reperfusion in Diabetic Patients Treated with Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content